Minor Oral Surgery with Out Stopping the Daily Low Dose of Aspirin Therapy

OBJECTIVES Patients with the low-dose long-term aspirin regime have a severe risk of excessive bleeding during surgery, placing them at risk of "adverse thrombotic events". This study aims to evaluate the bleeding in patients undergoing minor oral surgery procedures without stopping daily low-dose aspirin therapy. METHODOLOGY A descriptive cross-sectional hospital-based investigation involved the patient with minor oral surgery at "Altamash Institute of Dental Medicine, Karachi, Pakistan" from mid-April 2021 to mid-June 2021, who were between the age group 30 to 75 with a low-dose aspirin regime. The data was collected via a questionnaire to record the variables, i.e. duration of aspirin, postoperative medications, platelets count, clotting time, normal bleeding time, and intraoperative bleeding time.  RESULTS 51 patients, of which 32 were males while 19, were females. The normal bleeding time was comparatively analyzed with the intraoperative bleeding time using SPSS statistical software version 22. The results revealed that the mean bleeding time for the patients with a low-dose aspirin regime during minor oral surgery was 5.49 ± 1.07, while for the patients with a stopped aspirin dose was 4.57 ± 1.07. The comparative analysis using a t-test doesn't reveal significant statistical differences of p<0.05 between both groups. CONCLUSION We concluded that minor oral surgical procedures could safely be done without altering or stopping the low-dose, long-term aspirin regime.

Association between Diabetes Mellitus and Pancreatic Cancer: A Comprehensive Narrative Review

Pancreatic cancer (PC) is extremely aggressive, with symptoms occurring only in the advanced stage. The relationship between Type 2 Diabetes Mellitus (T2DM) and PC is complex. However, it is unclear whether long-standing diabetes causes cancer or whether cancer proceeds the development of impaired glucose metabolism. PubMed, Google Scholar, Scopus and Cochrane library were consulted to look for relevant literature. We narrowed down 20 articles after implementing inclusion and exclusion criteria. The database was searched using the keywords “Pancreatic Cancer” AND “Diabetes Mellitus.” This narrative literature review aims to analyze the literature on the analysis of the metabolic association of T2DM, the risk of carcinogenesis of the pancreas and their association, and the current understanding of metabolic pathways involved in cellular growth and metabolism. About 80% of patients with pancreatic disease have a previous diagnosis of diabetes within five years. We explored the literature to find metabolic associations between PC and T2DM due to insulin resistance, hyperinsulinemia, hyperglycemia, low-grade chronic inflammation, and insulin-like growth factor axis alteration